+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clot Management Procedure"

BRIC Clot Management Procedures Outlook to 2025 - Inferior Vena Cava Filters (IVCF) Procedures and Thrombectomy Procedures - Product Thumbnail Image

BRIC Clot Management Procedures Outlook to 2025 - Inferior Vena Cava Filters (IVCF) Procedures and Thrombectomy Procedures

  • Report
  • November 2020
  • 40 Pages
  • Brazil, China, India, ... Brazil, China, India, Russia
From
Loading Indicator

Clot Management Procedure is a surgical procedure used to treat blood clots in the body. It involves the use of a catheter to deliver clot-dissolving drugs, such as tissue plasminogen activator (tPA), to the affected area. The procedure is typically performed in a hospital setting, and is often used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). Clot management procedures can also be used to treat stroke, heart attack, and other conditions. The clot management procedure market is expected to grow in the coming years due to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive treatments. The market is also driven by the increasing number of clinical trials and the development of new technologies. Some of the major companies in the clot management procedure market include Boston Scientific Corporation, Medtronic, Abbott Laboratories, Johnson & Johnson, and Terumo Corporation. Show Less Read more